# New Castle Disease Virus (NDV) in Glioblastoma Multiforme (GBM), Sarcoma and Neuroblastoma

> **NCT01174537** · PHASE1,PHASE2 · WITHDRAWN · sponsor: **Hadassah Medical Organization**

## Conditions studied

- Glioblastoma
- Sarcoma
- Neuroblastoma

## Interventions

- **BIOLOGICAL:** New Castle Disease Virus

## Key facts

- **NCT ID:** NCT01174537
- **Lead sponsor:** Hadassah Medical Organization
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2011-07
- **Primary completion:** 2011-07
- **Final completion:** 2011-07
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2015-06-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01174537

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01174537, "New Castle Disease Virus (NDV) in Glioblastoma Multiforme (GBM), Sarcoma and Neuroblastoma". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01174537. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*